A Prospective Observational Study of Foam Sclerotherapy .
Recruiting
Observational Study
Autosomal Dominant Polycystic Kidney
Renal Cyst
Autosomal Dominant Polycystic Liver Disease
Hepatic Cyst
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 100
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Mayo Clinic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
An observational prospective study to determine the impact of foam sclerotherapy of large, dominant kidney/liver cysts on quality of life outcomes and kidney/liver cyst volumes at up to 12 months of follow-up in patients with autosomal dominant polycystic kidney disease (ADPKD) and autosomal dominant polycystic liver disease (ADPLD).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥18 years
* Clinical diagnosis of ADPKD or ADPLD
* 1-3 large, non-exophytic liver or kidney cyst
* Compressive symptoms from dominant cyst
Exclusion Criteria:
* Age \<18 years
* Absence of ADPKD or ADPLD
* Largest cyst \<4cm in all 3 dimensions or largest cyst volume \<4…
Contacts